John W. M. Martens - Erasmus MC Department of Medical Oncology Rotterdam The Netherlands

基本信息

浏览量：224

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 496 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation

Shuoying Qu,A. Mieke Timmermans,Bernadette A. M. Heemskerk-Gerritsen,Anita M. A. C. Trapman-Jansen, Renee Broeren-Foekens, Wendy J. C. van der Smissen, Hoesna El Hassnaoui, Tim van Tienhoven, Claudia K. Bes-Stobbe, Pieter J. Westenend,Carolien H. M. van Deurzen,John W. M. Martens,

Cancersno. 1 (2024): 28

引用0浏览0WOS引用

Abstract 3040: Tumor-specific super-enhancer drives overexpression of EVI1 in ovarian cancer

Leonie Smeenk, Sabrina Kruse,Roger Mulet-Lazaro,Ingrid Boere,John Martens, Stefan Gröschel, Claudia Scholl, Stefan Fröhling,Ruud Delwel

Cancer Researchno. 6_Supplement (2024): 3040-3040

引用0浏览0引用

TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer in near-clinical models

Dian Kortleve, Dora Hammerl,Mandy van Brakel, Rebecca Wijers,Daphne Roelofs, Kim Kroese,Mieke Timmermans,Chen-Yi Liao,Anita Trapman-Jansen, Rene Foekens,Justine Michaux, Monique de Beijer,

biorxiv（2024）

引用0浏览0引用

GRHL2 suppression of NT5E/CD73 in breast cancer cells modulates CD73-mediated adenosine production and T cell recruitment

Bircan Coban,Zi Wang,Chen-yi Liao, Klara Beslmüller,Mieke A.M. Timmermans,John W.M. Martens, Jasmijn Hundscheid,Bram Slutter,Annelien J.M. Zweemer, Elsa Neubert,Erik H.J. Danen

iSciencepp.109738, (2024)

引用0浏览0引用

Abstract 3282: Endocrine resistance genes driving cross-resistance to current combination therapies in HR-positive breast cancer

Zhangzan Huang, Noor Wortelboer,Corine Beaufort, Seda N. Ortak, Da-wei Chan, Hamit H. Dag, Jean Helmijr,John Martens,Maurice Jansen

Cancer Researchno. 6_Supplement (2024): 3282-3282

引用0浏览0引用

Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial

Noortje Verschoor,Manouk K. Bos,Ingeborg E. de Kruijff,Mai N. Van,Jaco Kraan,Jan C. Drooger, Johanna M. Zuetenhorst,Saskia M. Wilting,Stefan Sleijfer,Agnes Jager,John W. M. Martens

Breast Cancer Research and Treatmentpp.1-9, (2024)

引用0浏览0WOS引用

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

Roberto A Leon-Ferre,Sarah Flora Jonas,Roberto Salgado,Sherene Loi,Vincent de Jong, Jodi M Carter,Torsten O Nielsen,Samuel Leung,Nazia Riaz,Stephen Chia,Gérôme Jules-Clément,Giuseppe Curigliano,

JAMAno. 13 (2024): 1135-1144

引用0浏览0WOS引用

GRHL2 suppression of NT5E/CD73 in breast cancer cells modulates CD73-mediated adenosine production and T cell recruitment

Bircan Coban,Zi Wang,Chen-yi Liao, Klara Beslmüller,Mieke A.M. Timmermans,John W.M. Martens, Jasmijn Hundscheid, Bram Slutter, Annelien J.M. Zweemer, Elsa Neubert,Erik H.J. Danen

iScience (2024)

引用0浏览0引用

Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product

Michiel Stevens,Anouk Mentink,Frank A. W. Coumans,Eshwari Dathathri,Khrystany T. Isebia,Jaco Kraan, Ronald de Wit,John W. M. Martens,Leon W. M. M. Terstappen

MOLECULAR ONCOLOGY (2024)

引用0浏览0WOS引用

Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient

Titia G. Meijer,John W. M. Martens,Wendy J. C. Prager-van der Smissen,Nicole S. Verkaik,Corine M. Beaufort,Stanley van Herk,Teresa Robert-Finestra,Remco M. Hoogenboezem,Kirsten Ruigrok-Ritstier,Maarten W. Paul,Joost Gribnau,Eric M. J. Bindels,

Cancersno. 4 (2024): 741

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn